Skip to main content
SpringerLink
Log in

Identification of hemodynamically significant coronary artery stenoses by dipyridamole-magnetic resonance imaging and99mTc-methoxyisobutyl-isonitrile-SPECT

  • Original Papers
  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Abstract

Magnetic resonance imaging (MRI) has been used in conjunction with dipyridamole induced wall motion abnormalities for the noninvasive detection of coronary artery disease (CAD). To assess the clinical usefulness of dipyridamole-MRI for the localization of CAD and to evaluate the relation between dipyridamole induced wall motion abnormalities and myocardial perfusion 33 patients with severe CAD (>70% diameter reduction) underwent MRI at rest and after dipyridamole infusion (0.75 mg dipyridamole/kg over a period of 10 minutes). All patients performed exercise stress testing and 20 patients of the study group additionally had rest and exercise stress99mTc-methoxyisobutyl-isonitrile-SPECT (MIBI-SPECT). Two patients (6%) could not be evaluated due to severe motion artifacts during dipyridamole MRI.

Segmental wall motion and perfusion of corresponding short axis planes were related to the major coronary arteries using a standardized segmental coronary artery perfusion pattern. Detection of wall motion abnormalities or perfusion defects by 2 blinded observers in consensus was the criterion for grading a segment normal or pathologic. For localization of CAD, segmental gradings were related to the presumed coronary artery territories.

Stress-ECG was pathologic in 19/31 patients yielding a sensitivity of 61% and dipyridamole induced angina was present in 68% (21/31) of patients. Dipyridamole-MRI detected coronary artery disease with a sensitivity of 84% (26/31 patients) and all patients with new wall motion abnormalities also had dipyridamole induced angina. For the subgroup of 20 patients with MIBI-SPECT images, CAD was detected by both MIBI-SPECT and Dipyridamole-MRI in 90% (18/20) of patients. Dipyridamole-MRI and MIBI-SPECT gradings agreed in 55/60 (92%) coronary artery perfusion territories. There were no significant differences with respect to the sensitivities of Dipyridamole-MRI/MIBI-SPECT for the localization of individual coronary artery stenoses yielding 81%/78% for left anterior descending, 80%/80% for left circumflex and 92%/89% for right coronary artery stenoses. However, specificity of Dipyridamole-MRI (89%) for the detection of RCA stenoses was slightly better than for MIBI-SPECT (80%).

Dipyridamole-MRI induced regional wall motion abnormalities proved to be a highly sensitive parameter for the non-invasive localization of CAD. The similarity of dipyridamole-MRI and MIBI-SPECT results suggests a close agreement between functional and perfusion parameters in the assessment of hemodynamically significant coronary artery stenoses. The clinical utility of this MRI stress test is still limited by high cost and long imaging times which may, however, be overcome by the development of new shorter imaging sequences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CAD:

coronary artery disease

MRI:

magnetic resonance imaging

MIBI-SPECT:

99mTc-methoxyisobutyl-isonitrile-SPECT

References

  1. Sechtem U, Pflugfelder PW, White RD, Gould RG, Holt W, Lipton MJ, Higgins CB. Cine MR imaging: potential for the evaluation of cardiovascular function. AJR 1987; 148: 239–46.

    Google Scholar 

  2. Pflugfelder P, Sechtem U, White RD, Higgins CB. Quantification of regional myocardial function by rapid cine MR imaging. AJR 1988; 150: 523–9.

    Google Scholar 

  3. Lotan CS, Cranney GB, Bouchard A, Bittner V, Pohost GM. The value of cine nuclear magnetic resonance imaging for assessing ventricular function. J Am Coll Cardiol 1989; 14: 1721–9.

    Google Scholar 

  4. Schaefer S, Peshock RM, Parkey RW, Willerson JT. A new device for exercise MR imaging: AJR 1986; 147: 1289–90.

    Google Scholar 

  5. Pennell DJ, Underwood SR, Ell PJ, Swanton RH, Walker JM, Longmore DB. Dipyridamole magnetic resonance imaging: a comparison with thallium-201 emission tomography. Br Heart J 1990; 64: 362–9.

    Google Scholar 

  6. Baer FM, Smolarz K, Jungehülsing M, Beckwilm J, Theissen P, Sechtem U, Schicha H, Hilger HH. Feasibility of highdose dipyridamol-MRI for detection of coronary artery disease and comparison with coronary angiography. Am J Cardiol 1992; 69: 51–6.

    Google Scholar 

  7. Baer FM, Jungehulsing M, Sechtem U. MRI: Evaluation of ventricular function in coronary artery disease. In: van der Wall EE, de Roos A, (eds). Magnetic resonance imaging in coronary artery disease, Dordrecht: Kluwer Academic Publishers, 1991:191–215.

    Google Scholar 

  8. Taillefer R, Laflamme L, Dupras G, Picard M, Phaneuf DC, Leveille J. Myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile (MIBI): comparison of short and long time intervals between rest and stress injections. Eur J Nucl Med 1988; 13: 515–22.

    Google Scholar 

  9. Picano E, Morales MA, Distante A, Lattanzi F, Moscarelli E, Masini M Labbate A. Dipyridamole-echocardiography test in angina at rest: noninvasive assessment of coronary stenosis underlying spasm. Am Heart J 1986; 111: 688–91.

    Google Scholar 

  10. Bolognese L, Serasso G, Aralda D, Bongo AS, Rossi L, Rossi P. High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction: correlation with exercise testing and coronary angiography. J Am Coll Cardiol 1989; 14(2): 357–63.

    Google Scholar 

  11. Leppo J, Boucher CA, Okada RD, Newell J, Strauss HW, Pohorst GM. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenosis and relationship to regional wall motion. Circulation 1982; 66: 649–57.

    Google Scholar 

  12. Harris D, Taylor D. Condon B, Ackery D, Conway N. Myocardial imaging with dipyridamole: comparison of the sensitivity and specificity of thallium-201 versus MUGA. Eur J Nucl Med 1982; 7:1–5.

    Google Scholar 

  13. Lewen MK, Labovitz AJ, Kern MJ, Chaitman BR. Prolonged myocardial ischemia after intravenous dipyridamole thallium imaging. Chest 1987; 92:1102–4.

    Google Scholar 

  14. Friedmann HZ, Goldberg SF, Hauser AM, O'Neill WW. Death with dipyridamole-thallium imaging. Ann Intern Med 1988; 109: 990–1.

    Google Scholar 

  15. Camp A, Chaitman BR, Goodgold H, Byers S, Shaw L, Barth G, Samuels L. Intravenous dipyridamole: body weight considerations and dosage requirements. Am Heart J 1989; 117: 702–4.

    Google Scholar 

  16. Josephson RA, Weiss JL, Flaherty JE, Ouyang P, Shapiro EP. Dipyridamole echocardiography detects vulnerable myocardium in the early post-infarction period (Abstract) Circulation 1986; 74 (suppl II): 469.

    Google Scholar 

  17. Osterspey A, Jansen W, Tachuert M, Eigl J, Höpp H, Behrenbeck DW, Hilger HH. Stellenwert des Dipyridamol-Tests in der Diagnostik der koronaren Herzkrankheit. Deutsche Med Wochenschrift 1983; 108: 1469–75.

    Google Scholar 

  18. Picano E, Masini M, Lattanzi F, Distante A, L'Abbate A. High dose dipyridamole-echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986; 8: 848–54.

    Google Scholar 

  19. Vogel RA. Assessing stenosis significance by coronary arteriography: are the best variables good enough? J Am Coll Cardiol 1988; 12: 692–3.

    Google Scholar 

  20. Höffken H, Joseph K, Alexander C et al. 99mTc-2-Methoxy-Isobutyl-Isonitril in der Diagnostik der koronaren Herzkrankheit: Ergebnisse einer Multizenterstudie. Nucl. -Med 1990; 29:135–43.

    Google Scholar 

  21. Armstrong WF, O'Donnell JA, Ryan T, Feigenbaum H. Effect of prior myocardial infarction and extent and location of coronary artery disease on accuracy of exercise echocardiography. J Am Coll Cardiol 1987; 10: 531–8.

    Google Scholar 

  22. DePasquale EE, Nody AC, DePuey EG, Garcia EV, Pilcher G, Bredlay C, Roubin G, Gober A, Gruentzig A, Dàmoto P, Berger HJ. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 1988; 77: 316–27.

    Google Scholar 

  23. West DJ, Najm JC, Mistry R, Clarke SE, Fogelman I, Maisey MN. The localization of myocardial ischemia with technetium-99m methoxy isobutyl isonitrile and single photon emission computed tomography. Br Heart J 1989; 62: 303–13.

    Google Scholar 

  24. Kettunen R, Huikuri HV, Heikkilä J, Takkunen JT. Usefullness of technetium-99m-MIBI and Thallium-201 in tomographic imaging combined with high-dose dipyridamole and handgrip exercise for detecting coronary artery disease. Am J Cardiol 1991; 68: 575–79.

    Google Scholar 

  25. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-2methylpropyl-isonitrile. Circulation 1988; 77: 491–8.

    Google Scholar 

  26. Kahn JK, McGhie I, Akens MS, Sills MN, Faber TL, Kulkarni PV, Willerson JT, Corbett JR. Quantitative rotational tomography with 201-thallium and 99m Tc-2-methoxy-isobutyl-isonitrile: A direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989; 79: 1282–93.

    Google Scholar 

  27. Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ. A new Tc-99m-labeled myocardial imaging agent, hexakis (t-butylisonitrile)-technetium(I) (Tc-99m TBI): initial experience in human. J Nucl Med 1984; 5:1350–5.

    Google Scholar 

  28. Li QS, Frank TL, Franceschi D, Wagner HN, Becker LC. Technetium-99m methoxy isobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs. J Nucl Med 1988; 29:1539–48.

    Google Scholar 

  29. Wilson RF, Laughlin DE, Ackell PH et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 1985; 72: 82–92.

    Google Scholar 

  30. Feldmann RL, Nichols WW, Pepine CJ, Conti CR. Acute effects of intravenous dipyridamole on regional coronary hemodynamics and metabolism. Circulation 1981; 64: 333–44.

    Google Scholar 

  31. Baer FM, Smolarz K, Jungehulsing M, Beckwilm J, Theissen P, Sechtem U, Schicha H, Hilger HH. Chronic myocardial infarction: assessment of morphology, function and perfusion by gradient-echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile-SPECT. Am Heart J 1992; 123: 636–45.

    Google Scholar 

  32. Edelman RR, Thompson R, Kantor H, Brady TJ, Leavitt M, Dinsmore R. Cardiac function: Evaluation with fast-echo MR imaging. Radiology 1987; 162: 611–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klink III für Innere Medizin, Universität zu Köln, Joseph-Stelzmannstr. 9, W-5000, Köln 41, Germany

    Frank Michael Baer & Udo Sechtem

  2. Klinik und Poliklinik für Nuklearmedizin, Universität zu Köln, Joseph-Stelzmannstr. 9, W-5000, Köln 41, Germany

    Kamilla Smolarz, Peter Theissen, Eberhard Voth & Harald Schicha

Authors
  1. Frank Michael Baer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kamilla Smolarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Theissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eberhard Voth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harald Schicha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Udo Sechtem
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baer, F.M., Smolarz, K., Theissen, P. et al. Identification of hemodynamically significant coronary artery stenoses by dipyridamole-magnetic resonance imaging and99mTc-methoxyisobutyl-isonitrile-SPECT. Int J Cardiac Imag 9, 133–145 (1993). https://doi.org/10.1007/BF01151437

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01151437

Key words

Search

Navigation